People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Celldex Therapeutics, Inc. | — | Biotechnology | Series C | $64.5M | $2.6B | 2016 |
Richard H. Van Den Broek at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard H. Van Den Broek on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harry H Penner, Jr. | 1 | 6 |
| George O. Elston | 1 | 2 |
| Herbert J. Conrad | 1 | 1 |
| Avery W. Catlin | 1 | 1 |
| Timothy M. Shannon, M. D. | 1 | 1 |
| Anthony S. Marucci | 1 | 1 |
| Larry J. Ellberger | 1 | 1 |
| Karen O. Shoos | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.